Featured image of the article GaN companies consolidate their patent portfolios in Q4 2024 through patent filing surge and recent acquisitions.

GaN companies consolidate their patent portfolios in Q4 2024 through patent filing surge and recent acquisitions

SOPHIA ANTIPOLIS, France – February 19, 2025 │ The dynamic field of Gallium Nitride (GaN) technology continues to transform the semiconductor industry with notable advancements in patent activities. GaN’s unique properties set it apart as a critical material for high-performance power and RF applications. Recent data showcases significant strides in intellectual property (IP) activities that[…]

Featured image of the article Bispecific Antibodies and Cancer.

Bispecific Antibody & Cancer

SOPHIA ANTIPOLIS, France – January 31, 2025 │ KnowMade, a leading provider of patent analysis services, is pleased to present its most recent report, Bispecific Antibody & Cancer Patent Landscape Analysis 2025. The comprehensive report offers a thorough examination of the competitive landscape of bispecific antibody for cancer treatment from a patent perspective, providing crucial insights[…]

Featured image of the article Continued Innovation in mRNA Technology: Key Trends from Q4 2024 Patent Monitor.

Continued Innovation in mRNA Technology: Key Trends from Q4 2024 Patent Monitor

SOPHIA ANTIPOLIS, France – January 20, 2025 │ The therapeutic RNA landscape continues to evolve with a robust pace of innovation. The latest Q4 2024 edition of our Therapeutic mRNA patent monitor highlights significant developments in intellectual property activities, shedding light on key contributors and trends in this dynamic field. Key Highlights from Q4 2024[…]